Synopsis
Synopsis
0
EU WC
0
VMF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Hydrochloride, Pilocarpine
2. Isopilocarpine
3. Isoptocarpine
4. Nitrate, Pilocarpine
5. Ocusert
6. Pilocarpine
7. Pilocarpine Mononitrate, (3s-cis)-isomer
8. Pilocarpine Nitrate
9. Pilocarpine, Monohydrochloride, (3s-cis)-isomer
10. Salagen
1. 54-71-7
2. (+)-pilocarpine Hydrochloride
3. Pilocarpine Hcl
4. Almocarpine
5. Salagen
6. Adsorbocarpine
7. Pilocarpal
8. Pilocar
9. Pilocar Smp
10. Pilocarpine Monohydrochloride
11. Pilomiotin
12. Pilovisc
13. Pilocel
14. Sno Pilo
15. Mistura P
16. Pilocarpine Muriate
17. Epicar
18. Mi-pilo Ophth Sol
19. Pilopine Hs
20. Vistacarpin N
21. Pilocarpine, Hydrochloride
22. Spersacarpine Hydrochloride
23. Pilokarpin Monohydrochloride
24. Pilopine
25. Pilocarpine Chloride
26. Pilocarpine (hydrochloride)
27. Pilo
28. Pilocarpinum Muriaticum
29. Pilocarpine, Monohydrochloride
30. Pilocarpine Hydrochlororide
31. Mls000069454
32. 0ww6d218xj
33. Isoptocarpine
34. (3s,4r)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one;hydrochloride
35. Nsc5746
36. Smr000059053
37. Isopto Carpine
38. Isopto-carpine
39. Ami-pilo
40. Amistura P
41. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, Monohydrochloride, (3s,4r)-
42. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, Monohydrochloride, (3s-cis)-
43. Pilopine Hs Gel
44. Nsc 5746
45. (3s,4r)-3-ethyl-4-((1-methyl-1h-imidazol-5-yl)methyl)dihydrofuran-2(3h)-one Hydrochloride
46. (3s,4r)-3-ethyl-4-[(1-methyl-1h-imidazol-5-yl)methyl]dihydrofuran-2(3h)-one Hydrochloride
47. Einecs 200-212-5
48. Unii-0ww6d218xj
49. Pilocarpine-hcl
50. Ai3-61859
51. Sr-01000000054
52. Mi-pilo
53. Component Of Epicar
54. Salagen (tn)
55. Sanpilo (tn)
56. Component Of Pilocar
57. Pilocarpine Hydrochloride [usp:jan]
58. Vuity
59. Pilopine Hs (tn)
60. Isopto Carpine (tn)
61. Nsc-5746
62. Pilocarpini Hydrochloridum
63. Regid855931
64. Opera_id_1616
65. Schembl41427
66. Mls000758210
67. Mls001076314
68. Mls001424017
69. Nsc 5746 Hcl
70. Pilocarpine Hcl [vandf]
71. Chembl1200330
72. Dtxsid2041096
73. Chebi:141029
74. Hy-b0726
75. Tox21_500950
76. S4231
77. Pilocarpine Hydrochloride [mi]
78. Pilocarpinum Muriaticum [hpus]
79. Akos005267231
80. Pilocarpine Hydrochloride (jp17/usp)
81. Ccg-100757
82. Lp00950
83. Nc00007
84. Pilocarpine Hydrochloride [jan]
85. (3s,4r)-3-ethyl-4-[(1-methylimidazol-5-yl)methyl]-3,4,5-trihydrofuran-2-one, C Hloride
86. Ncgc00094254-01
87. Ncgc00261635-01
88. Pilocarpine Hydrochloride [mart.]
89. Pilocarpine Hydrochloride [vandf]
90. Ac-33119
91. Pilocarpine Hydrochloride [usp-rs]
92. Pilocarpine Hydrochloride [who-dd]
93. Pilocarpine Hydrochloride [who-ip]
94. Eu-0100950
95. Sw196587-4
96. D02200
97. D91961
98. P 6503
99. Pilocarpine Hydrochloride [ep Impurity]
100. Pilocarpine Hydrochloride [ep Monograph]
101. Pilocarpine Hydrochloride [orange Book]
102. Pilocarpine Hydrochloride [usp Impurity]
103. 2(3h)-furanone, Monohydrochloride, (3s-cis)-
104. Pilocarpine Hydrochloride [usp Monograph]
105. Pilocarpini Hydrochloridum [who-ip Latin]
106. Wln: T5ovtj C2 D1- Dt5n Cnj C1 &gh
107. Sr-01000000054-3
108. Sr-01000075339-1
109. Pilocarpine Hydrochloride, >=98% (titration), Powder
110. Q23059847
111. Betoptic Pilo Component Pilocarpine Hydrochloride
112. Pilocarpine Hydrochloride Component Of Betoptic Pilo
113. Pilocarpine Hydrochloride, Meets Usp Testing Specifications
114. Pilocarpine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
115. (3s,4r)-3-ethyl-4-[(1-methyl-1h-imidazol-5-yl)methyl]oxolan-2-one Hydrochloride
116. Pilocarpine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
117. Pilocarpine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
118. (3s-cis)-3-ethyldihydro-4-[(1-methyl-1h-imidazol-5-yl)methyl]-2(3h)-furanone Hydrochloride
119. 2(3h)-furanone, 3-ethyldihydro-4-((1-methyl-1h-imidazol-5-yl)methyl)-, Hydrochloride (1:1), (3s,4r)-
Molecular Weight | 244.72 g/mol |
---|---|
Molecular Formula | C11H17ClN2O2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 244.0978555 g/mol |
Monoisotopic Mass | 244.0978555 g/mol |
Topological Polar Surface Area | 44.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 245 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Isopto carpine |
PubMed Health | Pilocarpine |
Drug Classes | Dental Agent, Direct Acting Miotic |
Drug Label | Isopto Carpine (pilocarpine hydrochloride ophthalmic solution) is a cholinergic agonist prepared as a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structure:Established name: pilocarpine hydrochlorideChe... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Solution |
Route | Ophthalmic |
Strength | 1%; 2%; 4% |
Market Status | Prescription |
Company | Alcon Res |
2 of 8 | |
---|---|
Drug Name | Pilocarpine hydrochloride |
PubMed Health | Pilocarpine |
Drug Classes | Dental Agent, Direct Acting Miotic |
Drug Label | Pilocarpine hydrochloride tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. Pilocarpine hydrochloride is a hygroscopic, odorless, bitter tasting white crystal or powder, which is soluble in water and alcohol and virtually... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Corepharma; Roxane; Lannett; Impax Labs |
3 of 8 | |
---|---|
Drug Name | Pilopine hs |
Drug Label | SALAGEN Tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. Pilocarpine hydrochloride is a hygroscopic, odorless, bitter tasting white crystal or powder which is soluble in water and alcohol and virtually insoluble in mos... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Gel |
Route | Ophthalmic |
Strength | 4% |
Market Status | Prescription |
Company | Alcon |
4 of 8 | |
---|---|
Drug Name | Salagen |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Eisai |
5 of 8 | |
---|---|
Drug Name | Isopto carpine |
PubMed Health | Pilocarpine |
Drug Classes | Dental Agent, Direct Acting Miotic |
Drug Label | Isopto Carpine (pilocarpine hydrochloride ophthalmic solution) is a cholinergic agonist prepared as a sterile topical ophthalmic solution. The active ingredient is represented by the chemical structure:Established name: pilocarpine hydrochlorideChe... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Solution |
Route | Ophthalmic |
Strength | 1%; 2%; 4% |
Market Status | Prescription |
Company | Alcon Res |
6 of 8 | |
---|---|
Drug Name | Pilocarpine hydrochloride |
PubMed Health | Pilocarpine |
Drug Classes | Dental Agent, Direct Acting Miotic |
Drug Label | Pilocarpine hydrochloride tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. Pilocarpine hydrochloride is a hygroscopic, odorless, bitter tasting white crystal or powder, which is soluble in water and alcohol and virtually... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Corepharma; Roxane; Lannett; Impax Labs |
7 of 8 | |
---|---|
Drug Name | Pilopine hs |
Drug Label | SALAGEN Tablets contain pilocarpine hydrochloride, a cholinergic agonist for oral use. Pilocarpine hydrochloride is a hygroscopic, odorless, bitter tasting white crystal or powder which is soluble in water and alcohol and virtually insoluble in mos... |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Gel |
Route | Ophthalmic |
Strength | 4% |
Market Status | Prescription |
Company | Alcon |
8 of 8 | |
---|---|
Drug Name | Salagen |
Active Ingredient | Pilocarpine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 7.5mg; 5mg |
Market Status | Prescription |
Company | Eisai |
Muscarinic Agonists
Drugs that bind to and activate muscarinic cholinergic receptors (RECEPTORS, MUSCARINIC). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate. (See all compounds classified as Muscarinic Agonists.)
Miotics
Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here. (See all compounds classified as Miotics.)
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-17
Pay. Date : 2017-02-22
DMF Number : 10025
Submission : 1992-12-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9332
Submission : 1991-09-05
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-06-16
Pay. Date : 2017-05-17
DMF Number : 12388
Submission : 1997-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7536
Submission : 1988-05-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10861
Submission : 1994-02-28
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-11-10
Pay. Date : 2016-09-21
DMF Number : 16873
Submission : 2003-09-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8453
Submission : 1990-03-02
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-11-29
Pay. Date : 2023-11-24
DMF Number : 38901
Submission : 2023-09-30
Status : Active
Type : II
Certificate Number : R1-CEP 1999-005 - Rev 03
Status : Valid
Issue Date : 2021-10-25
Type : Chemical
Substance Number : 633
Certificate Number : R1-CEP 1997-034 - Rev 05
Status : Valid
Issue Date : 2023-06-08
Type : Chemical
Substance Number : 633
Certificate Number : CEP 2015-343 - Rev 02
Status : Valid
Issue Date : 2024-04-29
Type : Chemical
Substance Number : 633
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
About the Company : Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established...
About the Company : Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business as well as dee...
About the Company : C² PHARMA is a Luxembourg-based pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds o...
About the Company : C² PHARMA is a Luxembourg-based pharmaceutical group established in 2014. It manufactures and distributes active pharmaceutical ingredients (APls) and complex chemical compounds o...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : With “Health for Humanity” and “Infinite Possibilities of the Development of Chemical Science and Technology” as our visions, Iwaki Seiyaku Company Ltd. has been always str...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
Patent Expiration Date : 2037-08-18
US Patent Number : 11129812
Drug Substance Claim :
Drug Product Claim :
Application Number : 217836
Patent Use Code : U-3741
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-08-18
Patent Expiration Date : 2037-08-18
US Patent Number : 9867810
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217836
Patent Use Code : U-3741
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-08-18
Patent Expiration Date : 2037-08-18
US Patent Number : 11974986
Drug Substance Claim :
Drug Product Claim :
Application Number : 217836
Patent Use Code : U-3741
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-08-18
Patent Expiration Date : 2037-08-18
US Patent Number : 10639297
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 217836
Patent Use Code : U-3741
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2037-08-18
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?